Induction of Human iPSC-Derived Cardiomyocyte Proliferation Revealed by Combinatorial Screening in High Density Microbioreactor Arrays
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Inducing cardiomyocyte proliferation in post-mitotic adult heart tissue is attracting significant attention as a therapeutic strategy to regenerate the heart after injury. Model animal screens have identified several candidate signalling pathways, however, it remains unclear as to what extent these pathways can be exploited, either individually or in combination, in the human system. The advent of human cardiac cells from directed differentiation of human pluripotent stem cells (hPSCs) now provides the ability to interrogate human cardiac biology in vitro, but it remains difficult with existing culture formats to simply and rapidly elucidate signalling pathway penetrance and interplay. To facilitate high-throughput combinatorial screening of candidate biologicals or factors driving relevant molecular pathways, we developed a high-density microbioreactor array (HDMA)--a microfluidic cell culture array containing 8100 culture chambers. We used HDMAs to combinatorially screen Wnt, Hedgehog, IGF and FGF pathway agonists. The Wnt activator CHIR99021 was identified as the most potent molecular inducer of human cardiomyocyte proliferation, inducing cell cycle activity marked by Ki67, and an increase in cardiomyocyte numbers compared to controls. The combination of human cardiomyocytes with the HDMA provides a versatile and rapid tool for stratifying combinations of factors for heart regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another group, which previously developed a high-throughput bioengineered human cardiac organoid platform [59], has generated organoids for the purpose of identifying pro-proliferative compounds, which was followed by validation and functional screening to identify hit compounds with side effects on contractility [56].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)
Duffy, D. C., McDonald, J. C., Schueller, O. J. A., & Whitesides, G. M. (1998) · Analytical Chemistry · doi:10.1021/ac980656z · Cited by 5,288
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,157
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Transient Regenerative Potential of the Neonatal Mouse Heart
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., & Sadek, H. A. (2011) · Science · doi:10.1126/science.1200708 · Cited by 2,545
Self-citationMicrofluidic Large-Scale Integration
Thorsen, T., Maerkl, S. J., & Quake, S. R. (2002) · Science · doi:10.1126/science.1076996 · Cited by 2,222
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
Chemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
Cited by
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Mills, R. J., Titmarsh, D. M., Koenig, X., Parker, B. L., Ryall, J. G., Quaife-Ryan, G. A., Voges, H. K., Hodson, M. P., Ferguson, C., Drowley, L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707316114 · Cited by 478
“As CHIR99021 could not rescue the reduction in proliferation in MM, we next hypothesized that the β-catenin and YAP1 act in synergy to activate proliferation for a number of reasons: (i) both β-catenin and YAP1 activated proliferation in immature hCOs (Fig.”
BackgroundMethodInfluentialSelf-citationMills, R. J., Parker, B. L., Quaife-Ryan, G. A., Voges, H. K., Needham, E. J., Bornot, A., Ding, M., Andersson, H., Polla, M., Elliott, D. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.009 · Cited by 312
Self-citationOrgan‐on‐chip models: Implications in drug discovery and clinical applications
Mittal, R., Woo, F. W., Castro, C. S., Cohen, M. A., Karanxha, J., Mittal, J., Chhibber, T., & Jhaveri, V. M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27729 · Cited by 234
Buikema, J. W., Lee, S., Goodyer, W. R., Maas, R. G., Chirikian, O., Li, G., Miao, Y., Paige, S. L., Lee, D., Wu, H., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.06.001 · Cited by 219
“While we and others have previously demonstrated the ability of canonical Wnt signaling activation or direct GSK-3β inhibition to transiently expand mouse and human PSC-CMs in vitro, the extent remained modest (<10-fold) (Buikema et al., 2013b; Mills et al., 2019; Sharma et al., 2018; Titmarsh et al., 2016; Uosaki et…”
BackgroundMethodInfluentialImproving pregnancy outcomes in humans through studies in sheep
Morrison, J. L., Berry, M. J., Botting, K. J., Darby, J. R. T., Frasch, M. G., Gatford, K. L., Giussani, D. A., Gray, C. L., Harding, R., Herrera, E. A., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00391.2017 · Cited by 171
Decellularized extracellular matrix mediates tissue construction and regeneration
Liu, C., Pei, M., Li, Q., & Zhang, Y. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0900-3 · Cited by 167
Stem Cell Culture and Differentiation in Microfluidic Devices Toward Organ-on-a-Chip
Zhang, J., Wei, X., Zeng, R., Xu, F., & Li, X. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0091 · Cited by 115
Ferreira, M. P. A., Talman, V., Torrieri, G., Liu, D., Marques, G., Moslova, K., Liu, Z., Pinto, J. F., Hirvonen, J. J., Ruskoaho, H. J., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201705134 · Cited by 91
Thomas, D., Cunningham, N. J., Shenoy, S., & Wu, J. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab115 · Cited by 90
“Although the precise molecular mechanism is still largely unknown, this method can help generate iPSC-CMs by 100-fold.(117,118) One of the major drawbacks of 2D culture platforms is that they do not allow uniform distribution of the small molecules that promote differentiation and growth.”
MethodUtility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
“Another group, which previously developed a high-throughput bioengineered human cardiac organoid platform [59], has generated organoids for the purpose of identifying pro-proliferative compounds, which was followed by validation and functional screening to identify hit compounds with side effects on contractility [56].”
BackgroundCellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Phang, R. J., Ritchie, R. H., Hausenloy, D. J., Lees, J. G., & Lim, S. Y. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac049 · Cited by 72
“germ layers, including bona fide cardiovascular cells, which can be cultured for extended periods of time allowing for chronic treatment of test compounds.(307,309,310) Importantly, unlike primary cardiomyocytes”
BackgroundRyoo, H., Kimmel, H., Rondo, E., & Underhill, G. H. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10627 · Cited by 75
“66 An upstream concentration gradient generator and downstream culture chambers were combined to efficiently determine the proper dosage of resveratrol to protect primary mouse chondrocytes.”
BackgroundBioengineering adult human heart tissue: How close are we?
Mills, R. J., & Hudson, J. E. (2019) · APL Bioengineering · doi:10.1063/1.5070106 · Cited by 68
Self-citationFan, C., Tang, Y., Zhao, M., Lou, X., Pretorius, D., Menasché, P., Zhu, W., & Zhang, J. J. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.03.003 · Cited by 66
Yang, H., Yang, Y., Kiskin, F. N., Shen, M., & Zhang, J. Z. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03470-w · Cited by 58
“…micro-bioreactor array, Titmarsh et al . screened agonists targeting Wnt, Hedge-hog, IGF, and FGF pathways and found that a Wnt activator, CHIR99021 (CHIR), had the greatest influence on promoting hiPSC-CM proliferation, which was also confirmed in engineered cardiac micro-tissues [26, 27].”
BackgroundMcLennan, H. J., Blanch, A. J., Wallace, S. J., Ritter, L. J., Heinrich, S. L., Gardner, D. K., Dunning, K. R., Gauvin, M. J., Love, A. K., & Thompson, J. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-27660-x · Cited by 52
Sharma, A., Zhang, Y., Buikema, J. W., Serpooshan, V., Chirikian, O., Kosaric, N., Churko, J. M., Dzilic, E., Shieh, A., Burridge, P. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24954-3 · Cited by 47
“4B,C, S2), a well-known mitogen 29 .”
Woo, L. A., Tkachenko, S., Ding, M., Plowright, A. T., Engkvist, O., Andersson, H., Drowley, L., Barrett, I. P., Firth, M. A., Åkerblad, P., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.12.015 · Cited by 37
“performed high content imaging of hiPSC-CMs using Ki67 at 24 h to assess responses to combinations of four agonists implicated in CM proliferation [25].”
BackgroundMethodTorrieri, G., Ferreira, M. P. A., Shahbazi, M., Talman, V., Karhu, S. T., Pohjolainen, L., Carvalho, C., Pinto, J. F., Hirvonen, J. J., Ruskoaho, H. J., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202109032 · Cited by 37
The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery
Friese, A., Ursu, A., Hochheimer, A., Schöler, H. R., Waldmann, H., & Bruder, J. M. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.05.007 · Cited by 37
Microfluidic three-dimensional cell culture of stem cells for high-throughput analysis
Kim, J. A., Hong, S., & Rhee, W. J. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i10.803 · Cited by 36
Fan, C., Fast, V. G., Tang, Y., Zhao, M., Turner, J. F., Krishnamurthy, P., Rogers, J. M., Valarmathi, M. T., Yang, J., Zhu, W., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.09.011 · Cited by 31
Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1
Fan, C., Oduk, Y., Zhao, M., Lou, X., Tang, Y., Pretorius, D., Valarmathi, M. T., Walcott, G. P., Yang, J., Menasché, P., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132796 · Cited by 29
“These chemicals included Ly294002 (PI3K inhibitor) (6), FGF1 (6, 7), SB203580 and VX702 (p38 MAPK inhibitors) (6), KN93 (Ca2+/calmodulin-dependent protein kinase II inhibitor) (8), Su1498 (Flk-1 inhibitor) (8), and CHIR99021 (Wnt activator and GSK3α and 3β inhibitor) (8, 9).”
Titmarsh, D. M., Tan, C., Glass, N. R., Nurcombe, V., Cooper-White, J. J., & Cool, S. M. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0343 · Cited by 27
Self-citationKempf, H., & Zweigerdt, R. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_30 · Cited by 29
Pushp, P., Nogueira, D. E. S., Rodrigues, C. A. V., Ferreira, F. C., Cabral, J. M. S., & Gupta, M. K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10061-2 · Cited by 27
A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons
Sridharan, B., Hubbs, C., Llamosas, N., Kılınç, M., Singhera, F. U., Willems, E., Piper, D. R., Scampavia, L. D., Rumbaugh, G., & Spicer, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-45265-1 · Cited by 23
Glass, N., Takasako, M., Er, P. X., Titmarsh, D., Hidalgo, A., Wolvetang, E., Little, M., & Cooper-White, J. (2020) · Science Advances · doi:10.1126/sciadv.aaw2746 · Cited by 26
“Microdevices can be designed to multiplex experiments, allowing for a large number of experiments to be simultaneously performed on a single device (16).”
Self-citationBioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
James, E. C., Tomaskovic‐Crook, E., & Crook, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063005 · Cited by 27
Kametani, Y., Tanaka, S., Wada, Y., Suzuki, S., Umeda, A., Nishinaka, K., Okada, Y., Maeda, M., Miyagawa, S., Sawa, Y., et al. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30724 · Cited by 14
“Similarly, CHIR‐99021, another GSK‐3I, promotes cardiomyocyte proliferation via the β‐catenin pathway (Sharma et al., 2018; Titmarsh et al., 2016).”
BackgroundFloy, M. E., Dunn, K. K., Mateyka, T. D., Reichardt, I. M., Steinberg, A. B., & Palecek, S. P. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.09.009 · Cited by 15
Isolation, Culture, and Live-Cell Imaging of Primary Rat Cardiomyocytes
Leone, M., & Engel, F. B. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0668-1_9 · Cited by 14
Integrated Perspective of Scaffold Designing and Multiscale Mechanics in Cardiac Bioengineering
Lou, L., Orikasa, K., Nautiyal, P., & Agarwal, A. K. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100075 · Cited by 13
Microfluidic Devices as Process Development Tools for Cellular Therapy Manufacturing
Hernandez, J. A., Heuer, C., Bahnemann, J., & Szita, N. (2021) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2021_169 · Cited by 23
Characterization of iCell cardiomyocytes using single-cell RNA-sequencing methods
Schmid, C., Wohnhaas, C. T., Hildebrandt, T., Baum, P., & Rast, G. F. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106915 · Cited by 16
Muckom, R. J., McFarland, S., Yang, C., Perea, B., Gentes, M., Murugappan, A., Tran, E., Dordick, J. S., Clark, D. S., & Schaffer, D. V. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26815 · Cited by 14
“Numerous insights have been gathered from miniaturization and high‐throughput studies of stem cell niche components (Brafman et al., 2009; Rasi Ghaemi et al., 2016; Soen et al., 2006; Titmarsh et al., 2016).”
BackgroundCardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy
Rhee, J., & Wu, J. C. (2018) · Circulation Research · doi:10.1161/circresaha.117.312287 · Cited by 12
“natorial screening approach, several small molecules enhancing iPSC-CM proliferation have also been identified.(13) Significant research efforts have been made to discover”
BackgroundGurner, K. H., Truong, T. T., Harvey, A. J., & Gardner, D. K. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa072 · Cited by 11
High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates
Muckom, R. J., Bao, X., Tran, E., Chen, E., Murugappan, A., Dordick, J. S., Clark, D. S., & Schaffer, D. V. (2020) · Science Advances · doi:10.1126/sciadv.aaz1457 · Cited by 11
Harnessing developmental cues for cardiomyocyte production
Maas, R. G. C., van den Dolder, F. W., Yuan, Q., van der Velden, J., Wu, S. M., Sluijter, J. P. G., & Buikema, J. W. (2023) · Development · doi:10.1242/dev.201483 · Cited by 9
The Use of Stem Cell-Derived Neurons for Understanding Development and Disease of the Cerebellum
Nayler, S., & Becker, E. B. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00646 · Cited by 10
Yuan, Q., Verbueken, D., Dinani, R., Kim, R., Schoger, E., Morsink, C. D., Simkooei, S. A., Kemna, L. J. M., Hjortnaes, J., Kuster, D. W. D., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.11.001 · Cited by 9
Correia, C., Christoffersson, J., Tejedor, S., El-Haou, S., Matadamas-Guzman, M. L., Nair, S., Dönnes, P., Musa, G., Rohman, M., Sundqvist, M., et al. (2024) · Cells · doi:10.3390/cells13161339 · Cited by 9
“…2 (product number R1017, Fujifilm Cellular Dynamics, Madison, WI, USA), ChiPS22 (product number Y00325, Takara Bio Europe, Swedish Filial, Gothenburg, Sweden), iPSC C32 (AIBN, The University of Queensland, Brisbane, Australia [32]) and SA121 (product number Y00020, Takara Bio Europe).”
BackgroundSelf-citationSarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
Yuan, Q., Maas, R. G. C., Brouwer, E. C. J., Pei, J., Blok, C. S., Popovic, M. A., Paauw, N. J., Bovenschen, N., Hjortnaes, J., Harakaľová, M., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9020043 · Cited by 9
Lee, S., Lim, J., & Kwak, B. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118597 · Cited by 8
Chadly, D. M., Oleksijew, A. M., Coots, K. S., Fernandez, J. J., Kobayashi, S., Kessler, J. A., & Matsuoka, A. J. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318783497 · Cited by 7
Tashiro, S., Le, M. N. T., Kusama, Y., Nakatani, E., Suga, M., Furue, M., Satoh, T., Sugiura, S., Kanamori, T., & Ohnuma, K. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.03.007 · Cited by 6
Effect of Cell Labeling on the Function of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Choi, S. W., Cho, Y.-W., Kim, J. G., Kim, Y.-J., Kim, E., Chung, H., & Kang, S. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc19138 · Cited by 4
“However, hiPSC-CMs exhibit very low levels of proliferation (31, 32).”
BackgroundApplication and prospects of high-throughput screening for in vitro neurogenesis
Zhang, S.-Y., Zhao, J., Ni, J.-J., Li, H., Quan, Z., & Qing, H. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i6.393 · Cited by 4
Woo, L. A., Wintruba, K. L., Wissmann, B., Tkachenko, S., Kubicka, E., Farber, E., Engkvist, O., Barrett, I. P., Granberg, K. L., Plowright, A. T., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110485 · Cited by 4
Drug Discovery in Induced Pluripotent Stem Cell Models
Bourque, K., Mnasri, N., Jones-Tabah, J., Martins-Cannavino, K., & Hébert, T. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00049-9 · Cited by 1
IGFBP2 Mediates Human iPSC-Cardiomyocyte Proliferation in a Cellular Contact-Dependent Manner
Lee, S., Heinrich, P., Lee, D., Kang, Y., Robinson, H., Humphrey, S. J., Yun, J., Goodyer, W. R., Buikema, J. W., Paik, D. T., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326522 · Cited by 5
Self-citationTello, J. A., Jiang, L., Zohar, Y., & Restifo, L. L. (2023) · Neural Development · doi:10.1186/s13064-023-00174-y · Cited by 1
“There are precedents for applying microsystems technology to cell-based assays for drug screening [28, 166] to identify small molecules [152], peptides [114, 163], or antibodies [45, 140].”
BackgroundMechanisms and Therapeutic Potential of Human Cardiomyocyte Proliferation
McLane, R. D., Cheruku, A., Williams, A. B., & Karra, R. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13020074 · Cited by 2
Ortega, C., Corredor, D. A., Santillán, M., Ger, W. S., Noceda, C., Pais-Chanfrau, J.-M., & Trujillo, L. E. (2021) · Bionatura · doi:10.21931/rb/2021.06.03.31 · Cited by 1
Advanced microtechnologies for high-throughput screening
Rodrigues, A. L., Fernandes, T. G., Diogo, M. M., Cabral, J. M. S., & Dordick, J. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816221-7.00005-7 · Cited by 2
Borsoi, J. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2020.tde-15022021-164456 · Cited by 1
Lücker, P. B. (2018) · TSpace (University of Toronto)
Metadata
- Authors
- Titmarsh, D. M., Glass, N. R., Mills, R. J., Hidalgo, A., Wolvetang, E. J., Porrello, E. R., Hudson, J. E., & Cooper-White, J. J.
- Affiliations
- The University of Queensland (AU)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Corresponding author
- Titmarsh, Drew M.
- Cooper-White, Justin J.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-04-21
- Volume
- 6
- Issue
- 1
- Pages
- 24637-24637
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4838928
- OpenAlex
- W2337681077
- Cited by
- 59
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 7 · 2018: 11 · 2017: 4
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Australian National Fabrication Facility
- Stem Cells Australia
- Medical Research Council
- Australian Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- cardiomyocyte proliferation, human induced pluripotent stem cells, cardiomyocytes, microfluidic cell culture, combinatorial screening, Wnt signaling, Hedgehog signaling, IGF signalling, FGF signaling, CHIR99021, cardiac regeneration, cell cycle, Ki-67
- MeSH terms
- Cell Differentiation, Cells, Cultured, Humans, Reproducibility of Results, Signal Transduction, Myocytes, Cardiac, Cell Proliferation, Drug Discovery, Induced Pluripotent Stem Cells, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.